GlassScriptPhysician profile
James S Ebertowski
NPI 1932336203
$4,635.22
in general payments reported to CMS, 2019-2025
44 companies · $2,283 in 2025
The $2,283 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.15 · 2020: $133 · 2023: $748 · 2024: $1,383 · 2025: $2,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,311 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,311.27 |
| Education | $103.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $557.65 | 2023-2025 | Botox, Lupron Depot |
| Endo USA, INC. | $411.39 | 2024-2025 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $393.62 | 2023-2025 | Erleada |
| Teleflex LLC | $313.28 | 2023-2025 | Urolift, Barrigel, Deknatel |
| Sumitomo Pharma America, INC. | $257.00 | 2023-2025 | Gemtesa, Orgovyx |
| Medtronic, INC. | $188.69 | 2023-2025 | Interstim |
| Immunitybio, INC. | $165.64 | 2024-2025 | |
| Pfizer INC. | $146.95 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.40 | 2024-2025 | |
| Medtronic USA, INC. | $143.93 | 2019-2020 | |
| Astellas Pharma US INC | $135.29 | 2023-2025 | Xtandi, Myrbetriq |
| Procept Biorobotics Corporation | $120.44 | 2025 | |
| Urogen Pharma, INC. | $120.43 | 2023-2025 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $116.04 | 2023-2025 | Pylarify |
| Merck Sharp & Dohme LLC | $104.45 | 2023-2024 | Keytruda, Welireg, Lynparza |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $103.01 | 2023-2024 | Xiaflex, Aveed, Edex |
| Accord Healthcare, INC. | $90.81 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $89.87 | 2024 | |
| Azurity Pharmaceuticals, INC. | $85.41 | 2025 | Azmiro |
| Coloplast Corp | $76.96 | 2019 | |
| Sun Pharmaceutical Industries INC. | $70.47 | 2023-2024 | Yonsa |
| Becton, Dickinson and Company | $70.18 | 2023-2025 | Magic3 Go Intermittent Urinary Catheter, Bard Urinary Drainage Bag |
| Boston Scientific Corporation | $68.56 | 2023-2024 | Rezum Generator, Ams 700 |
| Olympus America INC. | $68.22 | 2025 | Tecoflex, Soltive |
| Antares Pharma, INC. | $65.90 | 2024-2025 | Xyosted |
| Karl Storz Endoscopy-America | $53.26 | 2024-2025 | N.A. |
| 180 Medical, INC. | $49.30 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $44.34 | 2025 | Purewick Female External Catheter |
| Inspire Medical Systems, INC. | $36.55 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Dendreon Pharmaceuticals LLC | $32.74 | 2023 | Provenge |
| Myriad Genetic Laboratories, INC. | $32.33 | 2023-2025 | Myrisk, Prolaris |
| Convatec INC. | $28.39 | 2023 | |
| Abc Home Medical Supply, INC. | $26.26 | 2025 | |
| Laborie Medical Technologies Corp. | $25.80 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Alnylam Pharmaceuticals INC. | $24.33 | 2024 | Oxlumo |
| Blue Earth Diagnostics | $22.29 | 2024 | |
| Steris Corporation | $20.68 | 2024 | |
| Dentsply Ih Ab | $19.19 | 2024 | Lofric |
| Tolmar, INC. | $16.89 | 2024 | |
| Cook Medical LLC | $16.26 | 2024 | Resonance |
| Ferring Pharmaceuticals INC. | $15.96 | 2024 | Adstiladrin |
| Axonics, INC. | $14.63 | 2024 | Axonics |
| Valencia Technologies Corporation | $10.37 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ebertowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.